MedTrace Logo

Biomarkers for Human Heart Failure

NCT03905252 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 535

Last updated 2024-05-28

No results posted yet for this study

Summary

The purpose of this study is to establish the various ranges of proteins that can be assayed in the plasma and urine from hospitalized patients with all classes of heart failure and/or STEMI (ST-segment elevation myocardial infarction)/NSTEMI (Non-ST-segment elevation myocardial infarction), as well as history reviews.

Conditions

  • CHF

Interventions

OTHER

sample analysis

blood, Random urine sample and 24-hour urine samples

Sponsors & Collaborators

Principal Investigators

  • John C Burnett, M.D. · Mayo Foundation

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-08-31
Primary Completion
2024-02-29
Completion
2024-02-29

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03905252 on ClinicalTrials.gov